Drug Shortage Report for AURO-TADALAFIL
| Report ID | 199894 |
| Drug Identification Number | 02435926 |
| Brand name | AURO-TADALAFIL |
| Common or Proper name | TADALAFIL |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TADALAFIL |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 2 X 14 |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-07-24 |
| Estimated end date | 2024-05-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-29 |
| Company comments | Please be informed that alternative pack size is available for Auro-Tadalafil 5mg Tablets, in 30 bottles. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-10-02 | English | Compare |
| v3 | 2023-07-25 | English | Compare |
| v2 | 2023-07-24 | French | Compare |
| v1 | 2023-07-24 | English | Compare |